AUS
NZ
UK
CA
USA
IND
Else Nutrition Holdings Inc. (TSX:BABY), a leading company in plant-based nutrition for infants, toddlers, and children, has successfully closed its recent offering of Units (the "Offering"), marking a significant milestone in its strategic growth initiatives.
Details of the Offering
Else Nutrition issued a total of 13,245,033 Units at a price of US$0.151 per Unit, resulting in gross proceeds of US$2,000,000. Each Unit comprises one common share of the company and one common share purchase warrant. The warrants are exercisable to acquire additional common shares at US$0.151 per share until July 5, 2029.
The net proceeds from the Offering are earmarked for several key areas essential to Else Nutrition's expansion and operational enhancement:
Funding will support ongoing research efforts aimed at advancing the nutritional science behind Else Nutrition's plant-based products.
- Allocation towards sales and marketing activities to expand market reach and brand awareness globally.
- Enhancing inventory capacity to meet growing demand for Else Nutrition's innovative products.
- Providing flexibility for general corporate needs and operational expenses.
In connection with the Offering, Else Nutrition paid a cash fee of US$140,000 and issued 927,152 common share purchase warrants to an arms-length advisor. These warrants allow the advisor to purchase common shares at US$0.151 per share until July 5, 2029.
Else Nutrition filed an amended and restated prospectus supplement with the securities commissions in various Canadian provinces (excluding Quebec), updating its short-form base shelf prospectus dated November 10, 2023.
Additionally, as part of its strategic initiatives, Else Nutrition will amend existing warrants issued in June 2022 and November 2023 (collectively referred to as "Amended Warrants"). These amendments include reducing the exercise price of the Amended Warrants to US$0.151 per common share and extending the expiry date to July 5, 2029. All other terms of the Amended Warrants will remain unchanged, with the effective date of amendments set for July 12, 2024.
With the successful completion of the offering and strategic amendments to existing warrants, Else Nutrition is poised to strengthen its position as a leader in the plant-based nutrition sector. The company remains committed to innovation, sustainability, and meeting the nutritional needs of infants, toddlers, and children globally.
